ViQi, Inc., announces the appointment of Dr. Tong-Ming Fu to the ViQi Scientific Advisory Board.
This appointment will draw on Dr. Tong-Ming
Fu's expertise in virology and his experience with the ViQi
flagship AI-based assay AVIA™.
SANTA
BARBARA, Calif., June 18,
2024 /PRNewswire-PRWeb/ -- ViQi, Inc. (Santa Barbara, CA), a groundbreaking image
processing AI company in the life sciences sector, is pleased to
announce the appointment of Dr. Tong-Ming
Fu M.D., Ph.D, as the newest member of the ViQi Scientific
Advisory Board.
Measuring viral infection is one of the
foundation pieces for developing effective vaccines and antiviral
monoclonal antibodies against deadly viral diseases, such as
SARS-CoV2.
"Dr. Tong-Ming Fu brings years of
relevant expertise to our growing Scientific Advisory Board," said
Kathy Yeung, CEO of ViQi, Inc. "His
extensive experience in virology, immunology, and microbiology is
invaluable to ViQi's mission of leveraging computational resources
to more easily gain insights from image based data for a positive
societal impact. He will add a unique perspective in helping to
shape the ViQi portfolio of AI-based assays which drive scientific
discovery forward in a meaningful way."
Most recently, Dr. Tong-Ming Fu
was the Chief Scientific Officer for Infectious Diseases at IGM
Biosciences, Inc. and is an ongoing Adjunct Professor at Texas
Therapeutic Institute at The University of
Texas Health Science Center in Houston. He was the Head of
Sanofi Vaccine Research of North
America from 2019-2021 and was a prominent Research
Scientist in Vaccines and Biologics at Merck Research Laboratories
for over two decades. He received his MD from Peking University
Health Science Center and a PhD in Microbiology and Immunology from
The Milton S. Hershey Medical Center at The Pennsylvania State University.
"Measuring viral infection is one of the foundation pieces for
developing effective vaccines and antiviral monoclonal antibodies
against deadly viral diseases, such as SARS-CoV2. The power of
ViQi's Automated Viral Infectivity Assay [AVIA™] to rapidly
quantify viral infection with higher precision is game-changing for
virologists and vaccine researchers," said Dr. Tong-Ming Fu. "I was excited to work with the ViQi
team while at IGM and am looking forward to expanding on their
novel work in joining the ViQi Scientific Advisory Board."
Dr. Tong-Ming Fu has received a
number of awards in vaccine and biologics research over the past 25
years and was an Editorial Board Member for a handful of journals
including Vaccine and Nature Partners Journal for Vaccines (npj
Vaccines). He is a member of several organizations including
American Association of Immunologists, Sino-American Pharmaceutical
Association (SAPA), International Society for Vaccines, and
American Society for Microbiology. He has published over 100
scientific papers and holds over two dozen patents.
About ViQi
ViQi, a pioneering California-based image analysis company,
unlocks the power of artificial intelligence (AI) and cloud-based
software through the development of novel solutions that automate
cell and tissue-based assays, transforming subjective analysis into
objective, quantifiable results. We empower laboratories by making
image processing and data management not only accessible but also
efficient, ultimately accelerating breakthroughs in critical areas
like virology research, drug discovery, and gene therapy.
ViQi's flagship innovation is the Automated Viral Infectivity
Assay (AVIA™). AVIA utilizes AI to automatically quantify viral
particles even before they become visible to the human eye. This
translates into a faster and more accurate assessment of viral
activity, leading to significant advancements in vaccine
development and infectious disease research.
Media Contact
To learn more contact the ViQi team at
media@viqiai.com
Media Contact
Heather Lorenz, ViQi, Inc., 1
415-306-2819, marketing@viqi.org, www.viqiai.com
View original content to download
multimedia:https://www.prweb.com/releases/viqi-appoints-dr-tong-ming-fu-md-phd-to-its-scientific-advisory-board-to-accelerate-scientific-innovation-using-ai-and-imaging-302173955.html
SOURCE ViQi, Inc.